Antifibrotic effects of interleukin-10 on experimental hepatic fibrosis.

Zhang, Li-Juan; Zheng, Wei-Da; Chen, Yun-Xin; Huang, Yue-Hong; Chen, Zhi-Xin; Zhang, Sheng-Jun; Shi, Mei-Na; Wang, Xiao-Zhong

Zhang, Li-Juan; Zheng, Wei-Da; Chen, Yun-Xin; Huang, Yue-Hong; Chen, Zhi-Xin; Zhang, Sheng-Jun; Shi, Mei-Na; Wang, Xiao-Zhong.

Affiliation

Zhang LJ; Department of Gastroenterology, Union Hospital of Fujian Medical University, Fuzhou 350001, Fujian Province, China.

Hepatogastroenterology ; 54(79): 2092-8, 2007.

Article in En | MEDLINE | ID: mdl-18251166

Subject(s)

Fibrinolysis/physiology; Interleukin-10/physiology; Liver Cirrhosis, Experimental/metabolism; Actins/metabolism; Animals; Disease Models, Animal; Electrophoresis; Immunohistochemistry; Liver/cytology; Male; Matrix Metalloproteinase 2/metabolism; NF-kappa B/metabolism; Rats; Rats, Sprague-Dawley; Tissue Inhibitor of Metalloproteinase-1/metabolism; Transforming Growth Factor beta1/metabolism

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Interleukin-10 / Fibrinolysis / Liver Cirrhosis, Experimental Type of study: Prognostic_studies Limits: Animals Language: En Journal: Hepatogastroenterology Year: 2007 Type: Article Affiliation country: China

Search on Google

XML

PubMed Links